Compare Becton Dickinson and Co (BDX) vs Etsy Inc (ETSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Etsy Inc — how do they compare? Becton Dickinson and Co trades at $156 (market cap $41.51B), while Etsy Inc trades at $85.78 (market cap $7.88B). The key difference: Becton Dickinson and Co is far larger — about 5.3× Etsy Inc's market cap, and Becton Dickinson and Co pays a 2.79% dividend while Etsy Inc pays none. Which is the better fit depends on your goals.
| BDX | ETSY | |
|---|---|---|
Market Cap | $41.51B | $7.88B |
Sector | Health | Consumer Cyclical |
52-Week High | $185.39 | $83.06 |
52-Week Low | $135.49 | $44.05 |
Enterprise Value | $57.97B | $9.53B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
ETSY trades at $80.53, down 0.64% today, with strong technical momentum as the stock has rallied 40% over the past three months. The company shows mixed fundamentals with revenue stabilizing around $2.9B but net income declining to $163M in 2025. Recent earnings beats and positive analyst sentiment (48.9% buy ratings) support the bullish technical outlook, though valuation metrics remain elevated with a P/E of 30.85.
The outlook remains cautiously optimistic with AI-driven marketplace improvements and seller tools driving growth potential. Key risks include active buyer declines, competitive pressures from larger e-commerce players, and high debt levels. The stock trades near analyst consensus targets, suggesting limited near-term upside from current levels despite positive momentum indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
